Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
13-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
13-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #1128
advertisement
PLoS ONE
5
Showing records 1 to 5 |
Display all abstracts in
PLoS ONE
46300
Findings from a rapid assessment of avoidable blindness (RAAB) in Southern Malawi
Kalua K; Lindfield R; Mtupanyama M; Mtumodzi D; Msiska V
PLoS ONE
2011; 6: e19226
46303
Genes of the unfolded protein response pathway harbor risk alleles for primary open angle glaucoma
Carbone MA; Chen Y; Hughes GA; Weinreb RN; Zabriskie NA; Zhang K; Anholt RRH
PLoS ONE
2011; 6: e20649
46299
Optineurin is required for CYLD-dependent inhibition of TNF(alpha)-induced NF-(kappa)B activation
Nagabhushana A; Bansal M; Swarup G
PLoS ONE
2011; 6: e17477
46301
Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death
Gregory MS; Hackett CG; Abernathy EF; Lee KS; Saff RR; Hohlbaum AM; Moody KL; Hobson MW; Jones A; Kolovou P
PLoS ONE
2011; 6: e17659
46302
Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells
Ganesh BS; Chintala SK
PLoS ONE
2011; 6: e18305
Issue
13-2
Table of Contents
Editor's Selection
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept